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Summary
Pre-oxygenation using high-flow nasal oxygen can decrease the risk of desaturation during rapid sequence
induction in patients undergoing emergency surgery. Previous studies were single-centre and often in limited
settings. This randomised, international, multicentre trial compared high-flow nasal oxygen with standard
facemask pre-oxygenation for rapid sequence induction in emergency surgery at all hours of the day and night.
A total of 350 adult patients from six centres in Sweden and one in Switzerland undergoing emergency surgery
where rapid sequence induction was required were included and randomly allocated to pre-oxygenation with
100% oxygen using high-flow nasal oxygen or a standard tight-fitting facemask. The primary outcome was the
number of patients developing oxygen saturations <93% from the start of pre-oxygenation until 1 min after
tracheal intubation. Data from 349 of 350 patients who entered the study were analysed (174 in the high-flow
nasal oxygen group and 175 in the facemask group). No difference was detected in the number of patients
desaturating <93%, five (2.9%) vs. six (3.4%) patients in the high-flow nasal oxygen and facemask group,
respectively (p = 0.77). The risk of desaturation was not increased during on-call hours. No difference was seen
in end-tidal carbon dioxide levels in the first breath after tracheal intubation or in the number of patients with
signs of regurgitation between groups. These results confirm that high-flow nasal oxygen maintains adequate
oxygen levels during pre-oxygenation for rapid sequence induction.
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Introduction
Rapid sequence induction (RSI) is a high-risk procedure.
Patients undergoing emergency surgery are more likely to
develop hypoxia [1] and, therefore, pre-oxygenation before
anaesthesia induction is of critical importance [2].
Administration of low-flow oxygen with nasal cannulae has
been shown to extend the time until desaturation in an
apnoeic patient [3-5], but the incidence of desaturation
during RSI is still high [1,6] and contributes significantly to
adverse events and poor outcome [7,8].
High-flow nasal oxygen can be used to prolong apnoea
time up to 1 h [9] and has been used during laryngeal
surgery with apnoea times up to 30 min [10,11], and during
RSI [12,13]. In previous studies, high-flow nasal oxygen
during RSI has been compared with pre-oxygenation
conducted with a tight-fitting facemask, as this is standard
practice. It was demonstrated that high-flow nasal oxygen
preserved oxygen saturation to an equal extent as facemask
pre-oxygenation, with some other potential benefits [12,13].
Notably, these studies were single-centre and in a limited
number of patients. One of these studies was conducted
during office hours only [12] and both were strictly
monitored by the research groups [12,13]. It has previously
been shown that cognitive performance among staff and
patient outcomes can differ between day and night [14,15].
Therefore, it remains to be determined whether this
technique of pre- and peri-oxygenation during RSI is safe to
usemorewidely.
This study compared high-flow nasal oxygen with tight-
fitting facemask pre-oxygenation during RSI in patients
undergoing emergency surgery in several different centres
in two countries and at all times of the day and night.
Methods
This international, prospective, randomised, controlled
multicentre trial was conducted in six centres in Europe:
Karolinska University Hospital (Stockholm); Capio S:t G€oran
Hospital (Stockholm); South General Hospital (Stockholm);
Karlstad Central Hospital (Karlstad); Link€oping University
Hospital (Link€oping), all in Sweden; and at the University
Hospital of Bern, Switzerland, between March 2018 and
February 2020. Ethical and institutional approvals were
acquired in both countries before patient enrolment. Adult
patients undergoing emergency surgery where RSI was
planned were consecutively enrolled around the clock.
Exclusion criteria were: BMI > 35 kg.m-2; pregnancy; need
for non-invasive ventilation before anaesthesia; or not
reaching SpO₂ > 93% during pre-oxygenation. Patients
who had already been included and those unable to give
consent were also not analysed. Patients were asked to
participate during the pre-anaesthetic evaluation. Oral and
written information were given, and a consent form was
signed. Patients were randomly allocated to either pre-
oxygenation with high-flow nasal oxygen or with a tight-
fitting facemask. This was done using sealed envelopes
assigned in a 1:1 ratio in block sizes of 10.
On arrival in the operating theatre, ECG, pulse oximetry
and blood pressure measurement, invasive or non-invasive,
were applied. A majority of the centres used monitors and
SpO2 sensors manufactured by Philips (Intellivue MX800
with X2 or X3 and M1191B glove sensor or FAST SpO2,
Amsterdam, The Netherlands). One centre (Capio S:t G€oran
Hospital) used the Carescape monitor B650 (Datex
Ohmeda, Helsinki, Finland) and the TrueSignal SpO2 sensor
(GE Healthcare, Helsinki, Finland) while another (Link€oping
University Hospital) used a monitor manufactured by
Masimo (Masimo Corporation, Irvine, CA, USA). An
intravenous line was secured, and a standard infusion of
electrolyte solution was started. Patients were then placed
supine in a reverse Trendelenburg position. Rapid
sequence induction was performed according to local
routines at each hospital [16]. Drugs and doses used were
determined by the anaesthetist in charge. Pre-oxygenation
was conducted for a minimum of 3 min. High-flow nasal
oxygen was administered using specifically designed
cannulae (Optiflow TM, Fisher and Paykel Healthcare,
Auckland, New Zealand) with 30–50 l.min-1 of heated and
humidified oxygen. Patients could breathe with an open or
closed mouth. Once apnoea occurred, oxygen flow was
increased to 70 l.min-1 and administered continuously until
the tracheal tube was in place. In the standard group,
patients breathed 100% oxygen via a tight-fitting facemask
with a fresh gas flow of 10 l.min-1 delivered via a circle
system [2]. In both groups, chin lift and/or jaw thrust was
used during apnoea tomaintain an open airway.
Conditions at tracheal intubation, such as: Cormack-
Lehane laryngoscopy grade; number of attempts; need for
airway equipment other than the Macintosh laryngoscope
size 3; and signs of gastric regurgitation, were recorded.
During induction of anaesthesia, the duration of apnoea
(apnoea time) and the time needed to intubate the trachea
(intubation time) were measured. Apnoea time was defined
as start of apnoea until a carbon dioxide trace was visible
with capnography. The time needed to intubate the trachea
was measured from when the laryngoscope passed the
teeth until a carbon dioxide trace was visible with
capnography. The lowest SpO₂ from start of pre-
oxygenation until 1 min after intubation was noted. Patients
not reaching SpO₂ > 93% during pre-oxygenation were not
included. If a patient desaturated before intubation, the
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anaesthetist decided whether to start mask ventilation. The
lowest saturation beforemask ventilationwas then noted.
In both groups, end-tidal carbon dioxide (ETCO₂) was
measured immediately before the start of pre-oxygenation
via a tight occluding facemask delivering room air. In the
facemask group, ETCO₂ and end-tidal oxygen (ETO₂) were
also measured at the time of induction. In both groups,
ETCO₂ and ETO₂ were measured in the first breath after
tracheal intubation (Aisys Carestation, GE Healthcare,
Waukesha, WI, USA or FLOW-i, Maquet Critical Care AB,
Solna, Sweden/Avance CS2, GE Healthcare, Waukesha, WI,
USA). Collection of data ended 1 min after intubation.
Office hours were defined as Monday to Friday, 07.30 to
16.00. All other timeswere defined as on-call hours.
Primary outcome was the number of patients who
developed oxygen saturation <93% from the start of pre-
oxygenation until 1 min after intubation. Our secondary
outcomes investigated end-tidal gas concentrations in the
first breath after intubation and number of patients with
signs of gastric regurgitation. We also explored differences
between centres as well as the effect of office hours vs. on-
call hours.
The primary outcome was difference in number of
patients developing oxygen saturation <93% on a
peripheral pulse oximeter. In a previous study of RSI, none
of the patients pre-oxygenated with high-flow nasal oxygen
desaturated to <93% vs. 12.5% in the facemask group [12].
In accordance with this, we based the sample size
calculation on the assumption of 10% desaturation in the
facemask group and 2.5% in the high-flow nasal oxygen
group. Using a type-1 error of 5% and a type-2 error of 20%
(power 80%), a sample size of 326was estimated. In order to
adjust for a slightly different result and dropouts, we aimed
to include 350 patients.
Differences between the groups were investigated
using an unpaired two-sample t-test or a Mann–Whitney U-
test depending on the distribution. Categorical data were
analysed using a Chi-square test or, in case of sample size
assumption violation, a Fisher’s exact test. The primary
outcome was analysed using a chi-square test. A value of
p < 0.05 was considered statistically significant. All tests
were performed using SPSS Statistics! 26 (IBM!, Armonk,
NY, USA).
Results
A total of 350 patients were randomly allocated to either
pre-oxygenation with high-flow nasal oxygen or facemask
(Fig. 1). One patient was not included because of a protocol
violation (the ventilator was mistakenly set to deliver room
air). Due to difficulties with tracheal intubation and a long
apnoea time, two patients were ventilated during the
apnoeic phase. One patient was ventilated during the
apnoeic phase without specification of the reason. All three
had SpO2 > 97 % when apnoea was interrupted. These
Figure 1 Study flowdiagram. A total of 350 patients were eligible; 114 patients were not included.One patient was not
includeddue to protocol violence.
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three patients were included in the results and data from a
total of 349 patients were, therefore, analysed. There were
no differences detected in patient or airway characteristics
between the groups (Tables 1 and 2). There was a slightly
longer apnoea time and intubation time in the high-flow
nasal oxygen group (Table 3). Other than that, conditions at
intubationwere similar between groups (Table 3).
No difference was seen in the number of patients
developing SpO2 < 93% between groups from the start of
pre-oxygenation until 1 min after intubation. Oxygen
saturation dropped <93% in five patients (2.9%) in the high-
flow nasal oxygen group compared with six (3.4%) in the
facemask group (p = 0.77) (Fig. 2). There was no difference
in lowest mean SpO2 from start of pre-oxygenation until
1 min after intubation between the groups: mean (SD)
99.1% (2.5%) vs. 99.0% (2.8%) in the high-flow nasal oxygen
and facemask group, respectively.
The number of patients developing SpO2 < 93% did
not significantly differ between centres (Fig. 3). There was,
however, a higher incidence of patients developing
SpO2 < 93% in Switzerland (7%) compared with Sweden
(1.6%) (p = 0.009). The same could be seen when only
looking at the high-flow nasal oxygen group where one out
of 124 (0.8%) Swedish patients desaturated <93% while 4
out of 50 (8%) Swiss patients did (p = 0.024). Furthermore,
Swiss patients having high-flow nasal oxygen had longer
apnoea and intubation times than those in Sweden: mean
(SD) 125.6 s (66.9 s) and 64.2 s (60.8 s) vs. 102.2 s (35.7 s)
and 47.2 s (24.2 s) (p = 0.004, p = 0.013).
A total of 214 patients were anaesthetised during office
hours and 135 during on-call hours. Of the 11 patients
developing SpO2 < 93%, 10 did so during office hours and
only one during on-call hours (p = 0.06). No difference in
levels of ETCO₂ in the first breath after intubation could be
seen between the groups (Table 3). There were, however,
higher levels of ETO2 seen in the first breath after tracheal
intubation in the facemask group (Table 3).
The person intubating the trachea was responsible for
inspecting the pharynx for any signs of regurgitation. This
was seen in one patient in the high-flow nasal oxygen group
and in none of the patients with facemask. The anaesthetist
in charge decided what drugs and doses were to be used
Table 1 Characteristics of 349 patients pre-oxygenated
with high-flow nasal oxygen or facemask for rapid sequence
induction of anaesthesia. Pulmonary comorbidity included
asthma (19), obstructive sleep apnoea syndrome (10),
chronic obstructive pulmonary disease (7), pleuritis/
pneumonia (5), lung cancer (3), pulmonary embolism (2),
pneumothorax (1), pulmonary fibrosis (1), pleural effusion
(1). Three patients had no condition specified and three
suffered a combination of pulmonary diseases. Surgery
specified as ‘other’ included ear, nose and throat and




n = 174 n = 175
Sex;male 86 (49.1) 89 (50.9)
Age; year 52.1 (20.7) 50.3 (18.7)
BMI; kg.m-2 25.1 (4.1) 25.5 (4.3)
Smoker 34 (19.5%) 32 (18.4%)
ASAphysical status
1 44 (25.3%) 57 (32.6%)
2 76 (43.7%) 59 (33.7%)
3 45 (25.9%) 43 (24.6%)
4 9 (5.2%) 15 (8.6%)
5 0 1 (0.6%)
Pulmonary comorbidity (other) 23 (13.2%) 32 (18.3%)
Pre-operativeO₂ treatment 12 (6.9%) 10 (5.7%)
Type of surgery
Abdominal 132 (75.9%) 119 (68.4%)
Intervention/endoscopy 17 (9.8%) 19 (10.9%)
Gynaecological/urological 8 (4.6%) 13 (7.5%)
Orthopaedic 13 (7.5%) 16 (9.2%)
Other 4 (2.3%) 7 (4.0%)
Table 2 Airway characteristics for 349 patients pre-
oxygenated with high-flow nasal oxygen or facemask for




n = 174 n = 175
ModifiedMallampati score
1 78 (46.4%) 73 (44.8%)
2 63 (40.5%) 62 (38.0)
3 22 (13.1%) 25 (15.3%)
4 5 (3.0%) 3 (1.8%)
Thyromental distance
>7 cm 112 (64.7%) 116 (66.7%)
6–7 cm 49 (28.3%) 48 (27.6%)
<6 cm 12 (6.9%) 10 (5.7%)
Mouth opening
>4 cm 145 (83.8%) 151 (86.3%)
2–4 cm 28 (16.2%) 24 (13.7%)
<2 cm 0 0
Neckmovement
Normal 164 (94.8%) 164 (93.7%)
Limited 9 (5.2%) 11 (6.3%)
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for each patient. In most cases, anaesthesia was
accomplished by using three different agents: one opioid,
one agent for induction and one neuromuscular blocking
drug. Even though the regimen varied between centres, the
drugs and doses did not differ between the two groups
(Table 3).
Discussion
In contrast with our previous paper [12], this study was
multicentre and conducted in all suitable patients requiring
RSI irrespective of the day or time. It showed no difference in
the number of patients desaturating <93% between pre-
oxygenation using high-flownasal oxygen vs. tight facemask.
More patients from the Swiss centre desaturated
compared with Sweden. We also observed longer mean
intubation and apnoea times among the Swiss patients in
the high-flow nasal oxygen group compared with the
Swedish patients pre-oxygenated with high-flow nasal
oxygen. Differences in the routines regarding RSI or not
sufficiently maintaining an open airway during apnoea
Table 3 Condition at intubation, secondary outcomes and drugs used for 349 patients pre-oxygenated with high-flow nasal
oxygen or facemask for rapid sequence induction of anaesthesia. Intubation adjuncts included use of Eschmann introducer,
Macintosh #4 or video laryngoscope. Some patients were given a combination of drugs from each group, represented in the
table as ‘combination’. Values are number (proportion), median (IQR [range]) ormean (SD).
High-flownasal oxygen Facemask
pn = 174 n = 175
Condition at intubation
Cormack–Lehane grade 0.46
1 126 (73.3%) 115 (66.1%)
2 37 (21.5%) 49 (28.2%)
3 7 (4.1%) 9 (5.2%)
4 2 (1.2%) 1 (0.6%)
Intubation attempts 1 (1–1 [1–4]) 1 (1–1 [1–4]) 0.83
Intubation adjuncts 84 (48.3%) 82 (46.9%) 0.61
Intubation time; s 52.1 (39.0) 47.6 (41.4) 0.015
Apnoea time; s 108.9 (47.8) 97.3 (53.4) 0.001
Secondary outcomes
ETCO₂ in first breath after intubation; kPa 4.64 (0.8) 4.56 (0.8) 0.33
ETO₂ in first breath after intubation (%) 76.7 (16.1) 84.9 (7.7) <0.001
Patientswith signs of regurgitation 1 (0.6%) 0 0.50
Drugs
Inductiondrug 0.17
Propofol 104 (59.8%) 102 (58.3%)
Thiopentone 58 (33.3%) 68 (38.9%)
Ketamine 4 (2.3%) 0
Etomidate 1 (0.6%) 0
Midazolam 0 0
Combination 7 (4.0%) 5 (2.9%)
Opioid 0.88
Fentanyl 96 (55.8%) 94 (54.3%)
Alfentanil 59 (34.3%) 59 (34.1%)
Remifentanil 8 (4.7%) 8 (4.6%)
Sufentanil 0 1 (0.6%)
Combination 10 (5.8%) 11 (6.4%)
Neuromuscular block 0.86
Succinylcholine 116 (66.7%) 118 (67.4%)
Rocuronium 58 (33.3%) 56 (32.0%)
Combination 0 1 (0.6%)
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might represent part of the explanation. Of the five patients
that desaturated in the high-flow nasal oxygen group, none
occurred during on-call hours. This suggests that the
anaesthetist and staff that work on call correctly manage the
technique of high-flow nasal oxygen including keeping the
airway open.
High-flow nasal oxygen has been shown to reduce the
increase in arterial carbon dioxide levels during apnoea by
approximately 50%, thus allowing longer periods of apnoea
[9, 10]. Recently, it has been demonstrated that high-flow
nasal oxygen may cause carbon dioxide clearance by flow-
dependent flushing [17]. In this study we demonstrated no
difference in ETO₂ levels between the groups in the first
breath after intubation even though the duration of apnoea
was longer in the high-flow nasal oxygen group (Table 3).
These results are in line with what has been presented in
previous studies [12, 13].
Oxygen concentration in the first breath after pre-
oxygenation was higher in the facemask group than in the
high-flow nasal oxygen group. It is possible that the tubes to
the ventilator have not been filled with 100% oxygen during
oxygenation with high-flow nasal oxygen, as occurs with use
of the facemask technique. The first breath given to the
patient after intubation will, therefore, contain room air.
This, in turn, affects the ETO₂ concentration in the first
breath after intubation. Also, during pre-oxygenation, some
of the patients in the high-flow nasal oxygen group were
breathing with their mouth open. The fraction of inspired
oxygen could, therefore, be lower than expected due to
dilution as previously shown [18]. This might have affected
the amount of oxygen stored in the lungs after pre-
oxygenation which, in turn, could have had an impact on the
ETO₂ in the first breath after intubation. Additionally, there is
some evidence suggesting that the time necessary to pre-
oxygenate above ETO₂ > 90% may be longer during high-
flow nasal oxygen compared to facemask [19]. The main
strength with high-flow nasal oxygen lies in its ability to
continuously deliver oxygen to an apnoeic patient, that is,
peri-oxygenation. The capacity of high-flow nasal oxygen to
store oxygen might, therefore, not have the same clinical
relevance as during traditional facemask pre-oxygenation
when oxygenation during apnoea ceases. End-tidal oxygen
has been used as a surrogate marker of the efficacy of pre-
oxygenation. This variable cannot be measured during
high-flow nasal oxygen and does not take the effect of
apnoeic peri-oxygenation into account. The effect of peri-
oxygenation is reflected in studies comparing apnoea times
when high-flow nasal oxygen or facemask is used during
pre- and peri-oxygenation, where longer apnoea times at
high oxygen saturation are seen using high-flow nasal
oxygen [20].
Figure 2 Oxygenation until 1 min after intubation. Lowest
SpO2 (%) from start of pre-oxygenation until 1 min after
intubation and apnoea time (s) is plotted for every patient
pre-oxygenatedwith high-flownasal oxygen (n = 174) or
facemask (n = 175). High-flownasal oxygen (red squares);
facemask (blue dots). Desaturationwas defined as
SpO2 < 93% (dotted line). *No intubation timewas noted.
Therefore, this patient had themean intubation time in the
high-flownasal oxygen group added to its apnoea time up
until the laryngoscope passed the teeth.
Figure 3 Lowest oxygen saturation amongpatients at the
different centres. Boxplot comparing the lowest SpO2 (%)
measured, from start of pre-oxygenation until 1 min after
tracheal intubation, between patients fromCapio S:t G€oran
Hospital (n = 50), Karolinska University Hospital (n = 49),
Link€opingUniversity Hospital (n = 50), SouthGeneral
Hospital (n = 50), KarlstadCentral Hospital (n = 50) and
University Hospital of Bern (n = 100) whenpre-oxygenated
with high-flownasal oxygen or facemask for rapid sequence
induction of anaesthesia. Desaturationwas defined as
SpO2 < 93% (dotted line). No difference in number of
patients desaturating below 93% could be seen between
the individual centres (p = 0.15). Dark horizontal bar
represents themedian, the edges of the box show IQR and
thewhiskers the lower quartile, except outliers and
extremes. Outlier and extremes are also shown.
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Concern has been raised whether the high flow of
oxygen delivered by high-flow nasal oxygen could cause
gastric distension and increase the risk of regurgitation. In
spontaneously breathing patients with closed mouth, it has
been shown that nasopharyngeal airway pressure increases
linearly with approximately 1 cmH₂O per 10 l.min-1 of flow
[21]. Recently, it has been shown that these pressures
correlate relatively well with the anaesthetised patient, when
the mouth is closed, and that airway pressure increases with
flow rate but remains below 10 cmH₂O even with flow rates
up to 80 l.min-1. Additionally, airway pressure is virtually
zero during high flows when the mouth is open [22].
Moreover, healthy volunteers using high-flow nasal oxygen
up to 70 l.min-1 in 30 min showed no signs of gastric
distension or increase in gastric secretions as assessed by
ultrasound [23]. Ventilating anaesthetised patients with a
facemask can cause gastric insufflation at a positive
pressure above 14 cmH₂O [24, 25]. Therefore, it seems
unlikely that high-flow nasal oxygen, even at maximum flow,
could cause gastric insufflation of gas. In the present study
there was one patient in the high-flow nasal oxygen group
with signs of regurgitation and none in the facemask group.
This study is obviously underpowered for such a rare event,
but we found it important to describe this variable in the
emergency surgery population since most studies
mentioned above were conducted in awake healthy
volunteers with assumed normal physiology in contrast to
anaesthetised emergency surgery patients.
Importantly, the purpose of RSI is to minimise apnoea
time before the airway is secured. In this study, mean
apnoea time was longer in the high-flow nasal oxygen
group compared with the facemask group. This pattern was
also seen in the study by Mir et al. [13]. Although high-flow
nasal oxygen can provide an extended safe apnoea time it is
important that RSI intubation is performed safely according
to routine practice, and without unnecessary delay.
However, a method that could prolong the time until
desaturation would be beneficial when dealing with a
difficult airway or critically ill patient [26]. Since patients
were included during all hours of the day, selection of a
special patient population was avoided. This increased the
generalisability of the technique and proved that high-flow
nasal oxygen can be a non-inferior substitute to facemask
pre-oxygenation also during on-call hours, when staff is
compromised, and timeoften is limited.
There are limitations to our study. It was not possible to
blind and we chose to set the desaturation level to 93% for
safety reasons. This is according to recommendations from
most parts of the world but constitutes a higher level of
saturation than some studies performed in Europe and
could, therefore, be considered a weakness. We did not
include obese patients and pregnant women, populations
that are known to be at high-risk for desaturation during
apnoea due to low functional residual capacity and high
metabolic demand. Furthermore, they may in addition
present a difficult airway. These patients might, therefore,
also benefit from peri-oxygenation using high-flow nasal
oxygen. We have shown that high-flow nasal oxygen is a
suitable method for pre- and peri-oxygention to maintain
adequate oxygen levels during RSI and is an alternative to
traditional facemask pre-oxygenation.
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